BK Virus (BKV) Infection Market Size

Market Size in USD Mn

CAGR41.9%

Study Period	2025-2032
Base Year of Estimation	2024
CAGR	41.9%
Market Concentration	High
Major Players	AlloVir, Amplyx Pharmaceuticals, SL VAXiGEN, Hybridize Therapeutics, Vera Therapeutics, Inc. and Among Others

*Disclaimer: Major players are listed in no particular order.

*Source: Coherent Market Insights

Want to purchase customized report?
please let us know !

BK Virus (BKV) Infection Market Analysis

The BK Virus (BKV) infection market is estimated to be valued at USD 48.3 Mn in 2025 and is expected to reach USD 559.5 Mn by 2032, growing at a compound annual growth rate (CAGR) of 41.9% from 2025 to 2032. The market is expected witness steady growth during the forecast period due to the rising prevalence of BKV infections among immunocompromised patients undergoing organ transplantation or receiving immunosuppressive therapy for autoimmune disorders.